Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

by | April 30, 2026 4:37 pm | US Markets

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.